Metabolic syndrome as a risk factor for Barrett esophagus: a population-based case-control study.

[1]  N. Takahashi,et al.  Distribution of body fat and its influence on esophageal inflammation and dysplasia in patients with Barrett's esophagus. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[2]  A. Chak,et al.  Insulin resistance, central obesity, and risk of colorectal adenomas , 2012, Cancer.

[3]  J. Lysaght,et al.  Role of the insulin‐like growth factor 1 axis and visceral adiposity in oesophageal adenocarcinoma , 2012, The British journal of surgery.

[4]  J. Reynolds,et al.  IGF-1 and Its Receptor in Esophageal Cancer: Association with Adenocarcinoma and Visceral Obesity , 2012, The American Journal of Gastroenterology.

[5]  C. la Vecchia,et al.  Metabolic syndrome and pancreatic cancer risk: a case-control study in Italy and meta-analysis. , 2011, Metabolism: clinical and experimental.

[6]  A. Chak,et al.  Association of insulin and insulin-like growth factors with Barrett's oesophagus , 2011, Gut.

[7]  A. Zinsmeister,et al.  Epidemiology and Natural History of Intestinal Metaplasia of the Gastroesophageal Junction and Barrett's Esophagus: A Population-Based Study , 2011, The American Journal of Gastroenterology.

[8]  B. Graubard,et al.  Metabolic syndrome increases the risk of primary liver cancer in the United States: A study in the SEER‐medicare database , 2011, Hepatology.

[9]  J. Reynolds,et al.  Obesity, metabolic syndrome and esophageal adenocarcinoma: epidemiology, etiology and new targets. , 2011, Cancer epidemiology.

[10]  S. Song,et al.  Old age and male sex are associated with increased risk of asymptomatic erosive esophagitis: Analysis of data from local health examinations by the Korean National Health Insurance Corporation , 2011, Journal of gastroenterology and hepatology.

[11]  B. Yawn,et al.  American Journal of Epidemiology Practice of Epidemiology Use of a Medical Records Linkage System to Enumerate a Dynamic Population over Time: the Rochester Epidemiology Project , 2022 .

[12]  I. Choi,et al.  Abdominal visceral adipose tissue volume is associated with increased risk of erosive esophagitis in men and women. , 2010, Gastroenterology.

[13]  L. Murray,et al.  A population-based study of IGF axis polymorphisms and the esophageal inflammation, metaplasia, adenocarcinoma sequence. , 2010, Gastroenterology.

[14]  C. la Vecchia,et al.  Metabolic syndrome is associated with colorectal cancer in men. , 2010, European journal of cancer.

[15]  A. Zinsmeister,et al.  Measurement of abdominal symptoms by validated questionnaire: a 3‐month recall timeframe as recommended by Rome III is not superior to a 1‐year recall timeframe , 2010, Alimentary pharmacology & therapeutics.

[16]  K. Flegal,et al.  Prevalence and trends in obesity among US adults, 1999-2008. , 2010, JAMA.

[17]  V. Pankratz,et al.  Metabolic Syndrome, Inflammation, and Nonamnestic Mild Cognitive Impairment in Older Persons: A Population-based Study , 2010, Alzheimer disease and associated disorders.

[18]  G. Block,et al.  Alcohol types and sociodemographic characteristics as risk factors for Barrett's esophagus. , 2009, Gastroenterology.

[19]  A. Yen,et al.  The effect of metabolic risk factors on the natural course of gastro-oesophageal reflux disease , 2008, Gut.

[20]  J. Reynolds,et al.  Barrett Esophagus: Prevalence of Central Adiposity, Metabolic Syndrome, and a Proinflammatory State , 2008, Annals of surgery.

[21]  H. Jung,et al.  Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case–control study of 7078 Koreans undergoing health check-ups , 2008, Gut.

[22]  T. Nozu,et al.  Clinical characteristics of asymptomatic esophagitis , 2008, Journal of Gastroenterology.

[23]  D. Corley,et al.  Abdominal Obesity and the Risk of Esophageal and Gastric Cardia Carcinomas , 2008, Cancer Epidemiology Biomarkers & Prevention.

[24]  D. Forman,et al.  A Systematic Review and Meta-Analysis of the Riskof Increasing Adiposity on Barrett's Esophagus , 2008, The American Journal of Gastroenterology.

[25]  N. Hayward,et al.  Leptin and the risk of Barrett’s oesophagus , 2007, Gut.

[26]  M. Bronner,et al.  Central adiposity and risk of Barrett's esophagus. , 2007, Gastroenterology.

[27]  G. Block,et al.  Abdominal obesity and body mass index as risk factors for Barrett's esophagus. , 2007, Gastroenterology.

[28]  J. Shaw,et al.  Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[29]  Michael Vieth,et al.  Prevalence of Barrett's esophagus in the general population: an endoscopic study. , 2005, Gastroenterology.

[30]  H. El‐Serag,et al.  Abdominal Obesity and the Risk of Barrett's Esophagus , 2005, The American Journal of Gastroenterology.

[31]  Richard Kahn,et al.  The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. , 2005, Diabetes care.

[32]  Claude Lenfant,et al.  Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Circulation.

[33]  Claude Lenfant,et al.  Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[34]  J R Bennett,et al.  The endoscopic assessment of esophagitis: a progress report on observer agreement. , 1996, Gastroenterology.

[35]  M. Yamagishi,et al.  Comparison of waist circumference with body mass index for predicting abdominal adipose tissue. , 2009, Diabetes research and clinical practice.

[36]  L. Bisanti,et al.  Metabolic syndrome and cancer risk. , 2008, European journal of cancer.